OTCBB:PCLOF
Pharmacielo Ltd Stock News
$0.220
+0 (+0%)
At Close: Jun 25, 2024
PharmaCielo Announces Issuance of Failure to File Cease Trade Order
07:54am, Wednesday, 08'th May 2024
All amounts expressed in Canadian dollars unless otherwise noted Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" o
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced invest
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
07:30am, Tuesday, 26'th Mar 2024
The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cul
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
07:00am, Thursday, 04'th Jan 2024
Austin, Texas and Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - January 4, 2024) - Benuvia Operations, LLC ("Benuvia"), a FDA registered, DEA licensed and cGMP certified leader in pharmac
PharmaCielo Announces Q3 2023 Financial Results
07:30am, Wednesday, 29'th Nov 2023
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCiel
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
07:40am, Friday, 06'th Oct 2023
Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000. The Company also announced that it has agreed to issue shares and debt in settlement of cert
PharmaCielo Announces Q2 2023 Financial Results
07:45am, Tuesday, 29'th Aug 2023
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"
PharmaCielo Provides Corporate Update
07:45am, Thursday, 10'th Aug 2023
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 10, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier c
PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO
09:00am, Tuesday, 11'th Jul 2023
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cul
PharmaCielo Stock Dives On Heels Of Closing Initial Tranche Of $3.92M Offering
10:18am, Monday, 03'rd Jan 2022
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX:PCLOF), the Canadian parent of Colombia's cannabis company PharmaCielo Colombia Holdings S.A.S.